Literature DB >> 14596499

The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of radiotherapy for cancer including a prospective survey of radiotherapy practice in Sweden 2001--summary and conclusions.

Ulrik Ringborg1, David Bergqvist, Bengt Brorsson, Eva Cavallin-Ståhl, Jeanette Ceberg, Nina Einhorn, Jan-Erik Frödin, Johannes Järhult, Gunilla Lamnevik, Christer Lindholm, Bo Littbrand, Anders Norlund, Urban Nylén, Måns Rosén, Hans Svensson, Torgil R Möller.   

Abstract

A systematic assessment of radiotherapy for cancer was conducted by The Swedish Council on Technology Assessment in Health Care (SBU) and published in 1996. The assessment reviewed the scientific literature up to 1993 on the use of radiotherapy in the treatment of solid tumours, and estimated the costs associated with radiotherapy. It also described the current practise of radiotherapy in Sweden 1992 and compared practise with scientific knowledge. The SBU has now conducted a follow-up study on radiotherapy for cancer, including a review of the scientific literature from 1994 and a prospective survey of radiotherapy practise in Sweden 2001. The following conclusions were drawn: The role of radiotherapy as an important form of treatment for cancer with both curative and palliative intent has been further confirmed. The use of radiotherapy in Sweden has increased and is now at the internationally recommended level. Radiotherapy in Sweden is mostly given in accordance with the scientific evidence but may still be underutilized in certain situations. The resources for radiotherapy are being utilized more efficiently. The costs of radiotherapy are still 5% of the total cost of cancer care, while the cost of an individual treatment (fraction) has decreased. The need for radiotherapy capacity will increase. In addition, half of the treatment equipment will have to be replaced in the next few years.

Entities:  

Mesh:

Year:  2003        PMID: 14596499     DOI: 10.1080/02841860310010826

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  54 in total

1.  Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer.

Authors:  J López Torrecilla; A Zapatero; I Herruzo; F A Calvo; M A Cabeza; A Palacios; A Guerrero; A Hervás; P Lara; B Ludeña Martínez; E Del Cerro Peñalver; G Nagore; G Sancho; J L Mengual; M Mira; A Mairiño; P Samper; S Pérez; I Castillo; J C Martínez Cedrés; E Ferrer; S Rodriguez; X Maldonado; A Gómez Caamaño; C Ferrer
Journal:  Clin Transl Oncol       Date:  2013-10-25       Impact factor: 3.405

Review 2.  Second malignant neoplasms and cardiovascular disease following radiotherapy.

Authors:  Lois B Travis; Andrea K Ng; James M Allan; Ching-Hon Pui; Ann R Kennedy; X George Xu; James A Purdy; Kimberly Applegate; Joachim Yahalom; Louis S Constine; Ethel S Gilbert; John D Boice
Journal:  J Natl Cancer Inst       Date:  2012-02-06       Impact factor: 13.506

3.  Radiation oncology: future needs and equipment. Current situation in Spain.

Authors:  Amalia Palacios Eito; María Espinosa Calvo; Ana Mañas Rueda; Manuel de Las Heras
Journal:  Clin Transl Oncol       Date:  2008-08       Impact factor: 3.405

Review 4.  Clinical Development of Novel Drug-Radiotherapy Combinations.

Authors:  Saif S Ahmad; Marka R Crittenden; Phuoc T Tran; Paul G Kluetz; Gideon M Blumenthal; Helen Bulbeck; Richard D Baird; Kaye J Williams; Tim Illidge; Stephen M Hahn; Theodore S Lawrence; Patricia A Spears; Amanda J Walker; Ricky A Sharma
Journal:  Clin Cancer Res       Date:  2018-11-29       Impact factor: 12.531

Review 5.  Targeting inflammatory pathways for tumor radiosensitization.

Authors:  Amit Deorukhkar; Sunil Krishnan
Journal:  Biochem Pharmacol       Date:  2010-06-30       Impact factor: 5.858

6.  Protective activity of a novel resveratrol analogue, HS-1793, against DNA damage in 137Cs-irradiated CHO-K1 cells.

Authors:  Min Ho Jeong; Kwang Mo Yang; Dong Hyeok Jeong; Chang Geun Lee; Su Jung Oh; Soo Kyung Jeong; Ki Won Lee; Young Rae Jo; Wol Soon Jo
Journal:  J Radiat Res       Date:  2014-01-07       Impact factor: 2.724

Review 7.  Cancer Cell Metabolism: Implications for X-ray and Particle Radiation Therapy.

Authors:  Mathieu Sertorio; John P Perentesis; Ralph E Vatner; Anthony E Mascia; Yi Zheng; Susanne I Wells
Journal:  Int J Part Ther       Date:  2018-09-21

8.  Genetically engineered mouse models for studying radiation biology.

Authors:  Katherine D Castle; Mark Chen; Amy J Wisdom; David G Kirsch
Journal:  Transl Cancer Res       Date:  2017-07       Impact factor: 1.241

Review 9.  The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention.

Authors:  Sarah L Kerns; Suman Kundu; Jung Hun Oh; Sandeep K Singhal; Michelle Janelsins; Lois B Travis; Joseph O Deasy; A Cecile J E Janssens; Harry Ostrer; Matthew Parliament; Nawaid Usmani; Barry S Rosenstein
Journal:  Semin Radiat Oncol       Date:  2015-05-15       Impact factor: 5.934

10.  Radiation-Drug Combinations to Improve Clinical Outcomes and Reduce Normal Tissue Toxicities: Current Challenges and New Approaches: Report of the Symposium Held at the 63rd Annual Meeting of the Radiation Research Society, 15-18 October 2017; Cancun, Mexico.

Authors:  Kelly C Falls; Ricky A Sharma; Yaacov R Lawrence; Richard A Amos; Sunil J Advani; Mansoor M Ahmed; Bhadrasain Vikram; C Norman Coleman; Pataje G Prasanna
Journal:  Radiat Res       Date:  2018-10       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.